The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex several-stage synthetic process. Initial routes focused on amino acid chain portion coupling, utilizing https://sachinaibr354792.mpeblog.com/73356412/synthesis-and-research-uses-of-retatrutide